Meet Caitlin: Caitlin has been partnering with Oxford for almost five years. She has worked with Epic™ since 2008, with a background in medical terminology and biological life sciences. Her entry into consulting was a happy accident — her recruiter called her by...
Carol Riegert, previously known as Carol Dingle, is the Senior Vice President and CIO at Oxford Global Resources. Her highly personable, well-spoken nature makes her an approachable, easy to talk to person with interesting stories to share. Get to know Carol in this...
Christopher Porcelli, Vice President of Recruiting, Information Technology at Oxford is a Long Island, New York native with a penchant for honesty and tenacity. His 21-year tenure at Oxford has allowed him to learn the business from the ground up, and he uses that...
Stefan Feldmeier, Technology Sales Director at Oxford, is a driven, competitive individual willing to introduce new ideas and face change head-on. In his tenure at Oxford, he has held several positions, all with the end goal of improving customer experience and...
21st Century Cures Act Affects on Health Information The 21st Century Cures Act will affect many components of the healthcare industry, including patients, providers, equipment vendors, and software vendors.1 Issued as a final rule in March 2020, the 21st Century...
Many industries have benefited from adopting new technologies, and the field of healthcare is no exception. The healthcare industry has witnessed change and welcomed the adoption of advancements over time; from the evolution of medical records in the 1920s to...
Featured Article by Vanessa Whitehead 2020 was to be a banner year for Mergers and Acquisitions (M&A) in the healthcare space. In the early months of the year, announced mergers were among the highest seen in the previous four years. Then, in March, the global...
Every day, organizations have the opportunity to gain insight into customer behavior, identify problems and opportunities, and improve efficiencies. The best way to inform these areas is through evaluating data. Gathering data can be a time-consuming and confusing...
The COVID-19 pandemic has given rise to extraordinary challenges for pharmaceutical companies with an unexpected, unmatched surge in demand for vaccines creating a difficult environment for pharmaceutical companies to keep up with production. Although this request...
